RAPT THERAPEUTICS INC. - COMMON STOCK
1.1800
24-January-25 16:45:00
15 minutes delayed
Stocks
-0.0100
-0.84%
Today's range
1.1500 - 1.2450
ISIN
N/A
Source
NASDAQ
-
RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis
13 Jun 2021 16:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference
20 May 2021 16:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports First Quarter 2021 Financial Results
11 May 2021 08:00:02 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis
22 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
-
RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results
11 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
-
10 Mar 2021 16:30:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Participate in Two Investor Conferences in March
03 Mar 2021 08:00:01 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
19 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 08:00:01 By Nasdaq GlobeNewswire